Correlation between carbide morphology and mechanical properties of 35XMA steel under multi-stage thermal exposure
Vibroengineering Procedia · 08.06.2026 · 62 · 439-444
DOI: 10.21595/vp.2026.26356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vibroengineering Procedia, online erschienen am 08.06.2026. Verfasst von Muzaffar Ubaydullaev und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The paper investigates the effect of multi-stage heat treatment modes on the microstructure and performance characteristics of modified 35KhML (35XMA) chromium-molybdenum steel. It was established that the application of a complex nano-modifier, combined with optimized double-stage tempering (600-650 °C), facilitates the transformation of a course as-cast structure into fine-dispersed sorbite. Particular attention is paid to the morphology of carbide phases and their role in preventing temper embrittlement. The results demonstrated a 45 % increase in impact toughness and a 20 % reduction in the abrasive wear rate.
Zitieren
APA
Ubaydullaev, M., Ruklinskaya, E., Kosimov, U., Khalikulov, U., & Musaev, E. (2026). Correlation between carbide morphology and mechanical properties of 35XMA steel under multi-stage thermal exposure. Vibroengineering Procedia, 62, 439-444. https://doi.org/10.21595/vp.2026.26356
Vancouver
Ubaydullaev M, Ruklinskaya E, Kosimov U, Khalikulov U, Musaev E. Correlation between carbide morphology and mechanical properties of 35XMA steel under multi-stage thermal exposure. Vibroengineering Procedia. 2026;62:439-444. doi:10.21595/vp.2026.26356
BibTeX
@article{Ubaydullaev2026,
author = {Ubaydullaev, Muzaffar and Ruklinskaya, Elena and Kosimov, Umidbek and Khalikulov, Utkir and Musaev, Emir},
title = {Correlation between carbide morphology and mechanical properties of 35XMA steel under multi-stage thermal exposure},
journal = {Vibroengineering Procedia},
year = {2026},
volume = {62},
pages = {439--444},
doi = {10.21595/vp.2026.26356}
}
EUVIMED